Autopsy report · NCT03879655

Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1

“Terminated by previous Sponsor decision”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year before it started.
• Ran for about 1 year 11 months before it stopped.
• 2 participants enrolled.
• Results were posted on the registry 2 years 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

Mandos LLC

Sponsor type

Industry

Conditions

Niemann-Pick Disease, Type C

Interventions

VTS-270

Participants

2

Sites

1

Countries

Costa Rica

Trials that died the same way

• ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases
  “Terminated - Sponsor Decision” (96% match in meaning)
• A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety
  “Terminated by sponsor” (92% match in meaning)
• Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
  “Sponsor Terminated” (90% match in meaning)
• Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
  “Terminated due to the sponsor's decision.” (89% match in meaning)
• Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis
  “Sponsor requested termination” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.